# Trade Mark Journal No.2026/013 27 March 2026

## WO0000001906837 (5)

Office of origin: United States of America

Date of International Registration:20 January 2026
Date of designation in the UK: 20 January 2026

Class 5
  Pharmaceutical preparation for the treatment of cancer in humans.

Celcuity Inc.

Representative: Anthony A Laurentano Nelson Mullins Riley & Scarborough LLP, One Financial Center, , Suite 3500, Boston MA 02111, UNITED STATES OF AMERICA